Leede Financial analyst Douglas Loe said in an Oct. 14 update that Cipher Pharmaceuticals (Cipher St... Read More
In a Sept. 16 note, Stifel analyst Justin Keywood reiterated a “Buy” rating and C$20.00 target o... Read More
Research Capital analyst Andre Uddin maintained a “Buy” rating and C$18.60 target for Cipher Pha... Read More
Following the company’s fourth quarter results, Leede Financial analyst Douglas Loe has upgrad... Read More
A meeting with management has increased the confidence level that Stifel analyst Justin Keywood has ... Read More
A recent development sent shares of Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Char... Read More
Following a major acquisition, Research Capital analyst Andre Uddin has raised his price target on C... Read More
Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Charts, News, Analysts, Financials TSX:C... Read More
Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Charts, News, Analysts, Financials TSX:C... Read More
Stifel GMP analyst Justin Keywood delivered an update to clients on Monday on Canadian specialty pha... Read More
Specialty Pharma name Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart, News TSX:CP... Read More
Following the company’s fourth quarter results, Stifel Canada analyst Justin Keywood has chopp... Read More
A new strategic focus from specialty pharma company Cipher Pharmaceuticals (Cipher Pharmaceuticals S... Read More
With the stock on a multi-year decline and the board looking at its “strategic options”,... Read More
Look for Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart TSX:CPH) to break out of ... Read More
Expect top line growth to reaccelerate for Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quot... Read More
Specialty pharma company Cipher Pharmaceuticals (Cipher Pharma Stock Quote, Chart: TSX:CPH) just ann... Read More
Soft Q1 financial results from Cipher Pharmaceuticals (TSX:CPH) are cause for a forecast revision fr... Read More
Share
Tweet
pin
Share